colforsin has been researched along with Granulocytic Leukemia, Chronic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kirken, RA; Oaxaca, DM; Rodriguez, G; Ross, JA; Staniswalis, JG; Yang-Reid, SA | 1 |
| Kan, WM; Xiao, LY | 1 |
| Assef, YA; Damiano, AE; Ibarra, C; Kotsias, BA; Zotta, E | 1 |
| Blaser, BW; Bloomfield, CD; Bruner-Klisovic, R; Caligiuri, MA; Chang, JS; Galietta, A; Liu, S; Mao, H; Marcucci, G; Neviani, P; Notari, M; Perrotti, D; Roy, DC; Santhanam, R; Trotta, R; Uttam, A; Valtieri, M | 1 |
| Savage, N; Weitzmann, MN | 1 |
| Song, LN | 1 |
6 other study(ies) available for colforsin and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Sensitivity of imatinib-resistant T315I BCR-ABL CML to a synergistic combination of ponatinib and forskolin treatment.
Topics: Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; Colforsin; Drug Resistance, Neoplasm; Drug Synergism; Fusion Proteins, bcr-abl; HEK293 Cells; Hep G2 Cells; Humans; Imatinib Mesylate; Imidazoles; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mutation; Protein Kinase Inhibitors; Pyridazines; src-Family Kinases | 2016 |
Cyclic AMP (cAMP) confers drug resistance against DNA damaging agents via PKAIA in CML cells.
Topics: Bucladesine; Cell Death; Cisplatin; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinase Type I; DNA Damage; Drug Resistance, Neoplasm; Etoposide; Humans; Intracellular Space; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Signal Transduction | 2017 |
CFTR in K562 human leukemic cells.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Antibodies; Cell Membrane; Colforsin; Cyclic AMP; Cystic Fibrosis Transmembrane Conductance Regulator; Glyburide; Hematopoietic Stem Cells; Homeostasis; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Potentials; RNA, Messenger; Tumor Cells, Cultured | 2003 |
The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein.
Topics: Animals; Antineoplastic Agents; Benzamides; Blast Crisis; Cell Line, Transformed; Chromosomal Proteins, Non-Histone; Colforsin; DNA-Binding Proteins; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Histone Chaperones; Humans; Imatinib Mesylate; In Vitro Techniques; K562 Cells; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, SCID; Neoplasm Transplantation; Phosphoprotein Phosphatases; Piperazines; Protein Phosphatase 2; Pyrimidines; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2005 |
Cyclic adenosine 3',5'-monophosphate, a second messenger in interleukin-1 mediated K562 cytostasis.
Topics: Adenylyl Cyclases; Alkaloids; Bucladesine; Cell Division; Colforsin; Cyclic AMP; Humans; Interleukin-1; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Second Messenger Systems; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1993 |
Demonstration of vitamin D receptor expression in a human megakaryoblastic leukemia cell line: regulation of vitamin D receptor mRNA expression and responsiveness by forskolin.
Topics: Base Sequence; beta 2-Microglobulin; Calcitriol; Cell Differentiation; Cell Division; Colforsin; Cyclic AMP-Dependent Protein Kinases; DNA Primers; Gene Expression Regulation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Megakaryocytes; Molecular Sequence Data; Receptors, Calcitriol; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured; Up-Regulation | 1996 |